Core Laboratories Inc. Files 8-K on Financials
Ticker: CLB · Form: 8-K · Filed: Oct 22, 2025 · CIK: 1958086
Sentiment: neutral
Topics: financial-reporting, 8-k, oil-gas
TL;DR
CORE files 8-K with financial updates - check for details.
AI Summary
Core Laboratories Inc. /DE/ filed an 8-K on October 22, 2025, reporting on its Results of Operations and Financial Condition, and including Regulation FD Disclosures and Financial Statements. The filing details information related to the company's financial performance and regulatory compliance.
Why It Matters
This 8-K filing provides crucial updates on Core Laboratories' financial condition and operational results, which can impact investor decisions and market perception.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- Core Laboratories Inc. /DE/ (company) — Registrant
- October 22, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 713-328-2673 (phone_number) — Registrant's Telephone Number
- 6316 Windfern Road (address) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition', 'Regulation FD Disclosure', and 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on October 22, 2025.
What is the primary business of Core Laboratories Inc. /DE/?
The Standard Industrial Classification code [1389] suggests the company is in 'OIL, GAS FIELD SERVICES, NBC'.
Where are Core Laboratories Inc.'s principal executive offices located?
The principal executive offices are located at 6316 Windfern Road, Houston, TX 77040.
What is the company's state of incorporation?
Core Laboratories Inc. is incorporated in Delaware.
Filing Stats: 545 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2025-10-22 16:15:22
Key Financial Figures
- $0.01 — ch registered Common Stock (par value $0.01) CLB New York Stock Exchange Indi
Filing Documents
- clb-20251022.htm (8-K) — 56KB
- clb-ex99_1.htm (EX-99.1) — 903KB
- img77179564_0.jpg (GRAPHIC) — 1257KB
- 0001193125-25-246793.txt ( ) — 2836KB
- clb-20251022.xsd (EX-101.SCH) — 31KB
- clb-20251022_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On October 22, 2025, Core Laboratories Inc. issued a press release announcing its financial results for the third quarter of 2025.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On October 22, 2025, Core Laboratories Inc. issued a press release announcing a quarterly cash dividend of $0.01 per share of common stock for shareholders of record on November 3, 2025 and payable November 24, 2025. The full text of the press release is set forth in Exhibit 99.1 attached hereto. The information in this Report and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly stated by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Press release issued on October 22, 2025 * 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * This exhibit is intended to be furnished and shall not be deemed "filed" for purposes of the Exchange Act.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Laboratories Inc. Dated: October 22, 2025 By /s/ Christopher S. Hill Christopher S. Hill Chief Financial Officer